Research aiming to make laboratory-grown leukaemia cells change form and used to prime a patient's immune system to kill malignant cells has begun in Scotland.
If successful the project could give clinicians a way of destroying residual leukaemic cells which are undetectable by microscope. The findings could be helpful in the treatment of acute myeloblastic leukaemia, one of the most common forms of leukaemia in adults.
Complete this month's questionnaire to qualify for extra Continuing Education credits. Click here For the answers to last month's quiz click here.
PHARMACY AWARDS
Click here for entry details for the 2003 Zuellig Pharma/Pharmacy Today Awards and to find out last year's winners. Also view and purchase photos of the 2002 Awards.
THIS ISSUE
For the leading stories in our latest issue of Pharmacy Today magazine visit our welcome page.
SUBSCRIPTIONS
To subscribe to Pharmacy Today, or to purchase The Beauty Manual or The Pharmacy Healthcare Handbook click here.
